» Articles » PMID: 6446278

Levels of Gamma-aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders

Overview
Journal Arch Neurol
Specialty Neurology
Date 1980 Jun 1
PMID 6446278
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Levels of gamma-aminobutyric acid (GABA) in CSF were measured by the ion exchange-fluorometric method in 136 patients who underwent evaluation for neurologic disorders. In 19 patients with no organic neurologic or mental disorders who acted as normal controls, the mean (+/-SD) GABA level in CSF was 239 +/- 76 picomoles/mL. Patients with acute hypoxic encephalopathy showed a mean GABA level in CSF higher than that of the controls, a difference that was statistically significant. In all the other disorders studied, the mean GABA level in CSF was either equal to or lower than that found in the controls. Statistically significant reductions of the GABA level in CSF were seen in patients with Huntington's disease, dementias, cerebellar cortical atrophy, multiple sclerosis, epilepsy, and Parkinson's disease.

Citing Articles

Cladribine treatment improves cortical network functionality in a mouse model of autoimmune encephalomyelitis.

Schroeter C, Rolfes L, Gothan K, Gruchot J, Herrmann A, Bock S J Neuroinflammation. 2022; 19(1):270.

PMID: 36348455 PMC: 9641831. DOI: 10.1186/s12974-022-02588-7.


The potential roles of amino acids and their major derivatives in the management of multiple sclerosis.

Pashaei S, Yarani R, Mohammadi P, Emami Aleagha M Amino Acids. 2022; 54(6):841-858.

PMID: 35471671 DOI: 10.1007/s00726-022-03162-4.


GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer's disease.

Jimenez-Balado J, Eich T Semin Cell Dev Biol. 2021; 116:146-159.

PMID: 33573856 PMC: 8292162. DOI: 10.1016/j.semcdb.2021.01.005.


Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease.

Najm R, Jones E, Huang Y Mol Neurodegener. 2019; 14(1):24.

PMID: 31186040 PMC: 6558779. DOI: 10.1186/s13024-019-0324-6.


Enhanced remyelination during late pregnancy: involvement of the GABAergic system.

Kalakh S, Mouihate A Sci Rep. 2019; 9(1):7728.

PMID: 31118452 PMC: 6531481. DOI: 10.1038/s41598-019-44050-4.